Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 15474272)

Published in Eur Urol on November 01, 2004

Authors

G Corona1, L Petrone, E Mannucci, E A Jannini, R Mansani, A Magini, R Giommi, G Forti, M Maggi

Author Affiliations

1: Department of Clinical Physiopathology, Andrology Unit, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.

Articles by these authors

Y-chromosome microdeletions are not associated with SHOX haploinsufficiency. Hum Reprod (2013) 2.01

Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metab (2013) 1.77

Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2013) 1.76

Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2013) 1.71

Functional and ultrastructural features of DNA-fragmented human sperm. J Androl (2001) 1.69

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology (1996) 1.66

Psychopathological and clinical features of outpatients with an eating disorder not otherwise specified. Eat Weight Disord (2001) 1.65

Seminal vesicles ultrasound features in a cohort of infertility patients. Hum Reprod (2012) 1.62

Chronic widespread pain is associated with slower cognitive processing speed in middle-aged and older European men. Pain (2010) 1.58

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation. Hum Reprod (1998) 1.54

Doxycycline and the teeth. Lancet (1969) 1.50

Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2012) 1.49

Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. Diabetes Obes Metab (2009) 1.49

Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl (2009) 1.43

Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction. J Endocrinol Invest (2012) 1.42

Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2011) 1.42

State transitions, cyclic and linear electron transport and photophosphorylation in Chlamydomonas reinhardtii. Biochim Biophys Acta (1999) 1.38

Purification and properties of cytochrome f from parsley leaves. Biochim Biophys Acta (1965) 1.33

Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis. Diabetes Obes Metab (2012) 1.30

Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl (2010) 1.30

Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2013) 1.29

Complexity of attrition in the treatment of obesity: clues from a structured telephone interview. Int J Obes (Lond) (2006) 1.29

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res (2006) 1.20

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19

Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76  TeV. Phys Rev Lett (2012) 1.19

TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. Cell Mol Life Sci (2004) 1.19

Dipeptydil peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis (2009) 1.18

Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol (2013) 1.17

The Y chromosome and male fertility and infertility. Int J Androl (2003) 1.17

Intracellular calcium accumulation and responsiveness to progesterone in capacitating human spermatozoa. J Androl (1992) 1.16

Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16

Metabolic syndrome and lower urinary tract symptoms: the role of inflammation. Prostate Cancer Prostatic Dis (2012) 1.14

Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype. Endocrinology (2000) 1.13

Benign prostatic hyperplasia: a new metabolic disease? J Endocrinol Invest (2014) 1.12

The gr/gr deletion(s): a new genetic test in male infertility? J Med Genet (2005) 1.11

On the structure and function of reduced nicotinamide adenine dinucleotide phosphate-cytochrome f reductase of spinach chloroplasts. Eur J Biochem (1968) 1.11

Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study. Psychother Psychosom (2001) 1.10

Screening for binge eating disorder in obese outpatients. Compr Psychiatry (2000) 1.10

Phenotypic variation within European carriers of the Y-chromosomal gr/gr deletion is independent of Y-chromosomal background. J Med Genet (2008) 1.10

Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7  TeV. Phys Rev Lett (2012) 1.10

Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09

Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS Study. Int J Obes (Lond) (2007) 1.09

Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study. Aliment Pharmacol Ther (2013) 1.09

Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08

Hypogonadism and metabolic syndrome. J Endocrinol Invest (2011) 1.07

Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. J Endocrinol Invest (2007) 1.07

Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07

Testicular development involves the spatiotemporal control of PDGFs and PDGF receptors gene expression and action. J Cell Biol (1995) 1.07

Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. Best Pract Res Clin Endocrinol Metab (2013) 1.06

The Y chromosome-linked copy number variations and male fertility. J Endocrinol Invest (2011) 1.06

The effect of phytohaemagglutinin on the metabolism and gamma-globulin synthesis of human lymphocytes. Biochim Biophys Acta (1966) 1.05

Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05

Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. Int J Androl (2009) 1.04

Nuclear staining identifies two populations of human sperm with different DNA fragmentation extent and relationship with semen parameters. Hum Reprod (2008) 1.04

Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release. J Clin Endocrinol Metab (1984) 1.03

Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome. J Endocrinol Invest (2008) 1.03

Studies on the triphosphopyridine nucleotide-cytochrome f reductase of chloroplasts. J Biol Chem (1966) 1.01

The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. Int J Androl (2009) 1.01

A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters. J Endocrinol Invest (2009) 1.01

Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2013) 1.01

Aging and pathogenesis of erectile dysfunction. Int J Impot Res (2004) 1.00

Inventories for male and female sexual dysfunctions. Int J Impot Res (2006) 1.00

Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens. Endocrinology (1987) 1.00

Persistence of expression of the TMPRSS2:ERG fusion gene after pre-surgery androgen ablation may be associated with early prostate specific antigen relapse of prostate cancer: preliminary results. J Endocrinol Invest (2009) 0.99

Identification and characterization of functional nongenomic progesterone receptors on human sperm membrane. J Clin Endocrinol Metab (1998) 0.99

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis. Exp Clin Endocrinol Diabetes (2009) 0.99

Prevalence of chronic prostatitis in men with premature ejaculation. Urology (2001) 0.99

Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res Clin Pract (2012) 0.99

Identification, localization and functional activity of oxytocin receptors in epididymis. Mol Cell Endocrinol (2002) 0.99

Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99

Erectile dysfunction: from biochemical pharmacology to advances in medical therapy. Eur J Endocrinol (2000) 0.98